Study results according to the study.More than two-thirds of the executives surveyed said a state-mandated non-confidential reporting system discouraged reporting errors in hospitals own internal systemsAlmost say 80 percent of respondents, a state-mandated non-confidential reporting system would increase lawsuits against hospital and 73 percent said it had no effect or a negative effect on actual patient safety. .
Flexible ureteroscopy with holmium: YAG laser intracorporeal lithotripsy is currently the most versatile endoscopic treatment for stones, regardless of location and composition. During stone fragmentation, there is some risk of damage to peripheral devices when the laser directed on it accidentally. Patrick Honeck from Peter Alken group in Mannheim, Germany, Micesented the results of an in vitro study to investigate the effect of laser energy on guide wires and stone baskets bewerten.035 Bentson guide wire, 025 glidewire into Terumo, a 3 French Dormia basket and a 2.2 French tipless nitinol basket were of different diameters laser fiber (230 Mic..Among the factors cause actual results may vary materially from the forward , but are not, but are not restricted to, restrict the timing that the success and the cost of ring research, out-licensing endeavors and clinical studies, Arena ability to obtain additional financing and the timing and receipt of payments and charges, if any, from Arena employees.. Forward-Looking Statements – Certain statements contained in this news release are forward-looking a number of risks a number of risks and uncertainties. If at all looking statements include statements at which therapeutic applications APD125 and APD356 when or if Arena expected to next continued clinical testing on APD125 and APD356, and through Arena strategy, technology, preclinical and clinical programs, and the ability identifying and develop new drugs and other statements who are not historical facts.
To to at a leader insomnia clinical research center in France. – We believe APD125 represents a significant development opportunities because there is a bedroom mechanism is different of existing therapies and any other into late-stage development goals, said Jack Lief President and CEO. By to those different mechanism to is, out our connect both induce sleep and improves the quality of sleep. APD125 is our second internal discovery candidate with great market potential enter the clinic in this year that another important milestone ring 2004.